Keros Therapeutics
KROS
KROS
156 hedge funds and large institutions have $429M invested in Keros Therapeutics in 2025 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 48 increasing their positions, 40 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 161 → 156 (-5)
26% less capital invested
Capital invested by funds: $582M → $429M (-$153M)
27% less call options, than puts
Call options by funds: $12.5M | Put options by funds: $17M
Holders
156
Holding in Top 10
3
Calls
$12.5M
Puts
$17M
Top Buyers
| 1 | +$24.3M | |
| 2 | +$20.4M | |
| 3 | +$14.9M | |
| 4 |
D.E. Shaw & Co
New York
|
+$12.7M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$11.2M |
Top Sellers
| 1 | -$52M | |
| 2 | -$30M | |
| 3 | -$26.7M | |
| 4 |
Holocene Advisors
New York
|
-$19M |
| 5 |
JFG
Jefferies Financial Group
New York
|
-$13.7M |
